Thursday, September 1, 2011

Pharmacodynamics Objective test

Pharmacodynamics Objective test
Pharmacodynamics Practice Exam
Objective measures of the pharmacodynamic
1. Pharmacodynamics involves the study of following?
a) Mechanisms of drug action
b) Biotransformation of drugs in the organism
c) Distribution of drugs in the organism
d) Excretion of drug from the organism


2. Pick out the answer which is the most appropriate to the term “receptor”
a) All types of ion channels modulated by a drug
b) Enzymes of oxidizing-reducing reactions activated by a drug
c) Active macromolecular components of a cell or an organism which a drug molecule has to combine with in
order to elicit its specific effect
d) Carriers activated by a drug

3. Target proteins which a drug molecule binds are:
a) Only receptors
b) Only ion channels
c) Only carriers
d) All of the above


4. If an agonist can produce maximal effects and has high efficacy it’s called:
a) Partial agonist
b) Antagonist
c) Agonist-antagonist
d) Full agonist


5. An antagonist is a substance that:
a) Binds to the receptors and initiates changes in cell function, producing maximal effect
b) Binds to the receptors and initiates changes in cell function, producing submaximal effect
c) Interacts with plasma proteins and doesn’t produce any effect
d) Binds to the receptors without directly altering their functions

6. The substance binding to one receptor subtype as an agonist and to another as an antagonist is called:
a) Competitive antagonist
b) Irreversible antagonist
c) Agonist-antagonist
d) Partial agonist


7. Mechanisms of transmembrane signaling are the following EXCEPT:
a) Transmembrane receptors that bind and stimulate a protein tyrosine kinase
b) Gene replacement by the introduction of a therapeutic gene to correct a genetic effect
c) Ligand-gated ion channels that can be induced to open or close by binding a ligand
d) Transmembrane receptor protein that stimulates a GTP-binding signal transducer protein (G-protein) which in turn
generates an intracellular second messenger


8. Tick the substance which changes the activity of an effector element but doesn’t belong to second messengers:
a) cAMP
b) cGMP
c) G–protein
d) Calcium ions

9. Tick the substances whose mechanisms are based on interaction with ion channels
a) Sodium channel blockers
b) Calcium channel blockers
c) Potassium channels activators
d) All of the above


10. Give the definition for a therapeutical dose:
a) The amount of a substance to produce the minimal biological effect
b) The amount of a substance to produce effects hazardous for an organism
c) The amount of a substance to produce the required effect in most patients
d) The amount of a substance to accelerate an increase of concentration of medicine in an organism



11. Which effect may lead to toxic reactions when a drug is taken continuously or repeatedly?
a) Refractoriness
b) Cumulative effect
c) Tolerance
d) Tachyphylaxis


12. What term is used to describe a decrease in responsiveness to a drug which develops in a few minutes?
a) Refractoriness
b) Cumulative effect
c) Tolerance
d) Tachyphylaxis

13. Drug resistance is a term used to describe the loss of effectiveness of antimicrobial or antitumour drugs. This
consideration is:
a) True
b) False



14. Tolerance and drug resistance can be a consequence of:
a) Change in receptors, loss of them or exhaustion of mediators
b) Increased receptor sensitivity
c) Decreased metabolic degradation
d) Decreased renal tubular secretion

15. Dependence is often associated with tolerance to a drug, a physical abstinence syndrome, and psychological
dependence (craving). This consideration is:
a) True
b) False


16. What is the type of drug-to-drug interaction which is connected with processes of absorption, biotransformation,
distribution and excretion?
a) Pharmacodynamic interaction
b) Physical and chemical interaction
c) Pharmaceutical interaction
d) Pharmacokinetic interaction


17. What phenomenon can occur in case of using a combination of drugs?
a) Tolerance
b) Tachyphylaxis
c) Accumulation
d) Synergism


18. What does the term “potentiation” mean?
a) Cumulative ability of a drug
b) Hypersensitivity to a drug
c) Fast tolerance developing
d) Intensive increase of drug effects due to their combination


19. The term “chemical antagonism” means that:
a) two drugs combine with one another to form an inactive compound
b) two drugs combine with one another to form a more active compound
c) two drugs combine with one another to form a more water soluble compound
d) two drugs combine with one another to form a more fat soluble compound


20. Characteristic unwanted reaction which isn’t related to a dose or to a pharmacodynamic property of a drug is called:
a) Idiosyncrasy
b) Hypersensitivity
c) Tolerance
d) Teratogenic action


21. Therapeutic index (TI) is:
a) A ratio used to evaluate the safety and usefulness of a drug for indication
b) A ratio used to evaluate the effectiveness of a drug
12
c) A ratio used to evaluate the bioavailability of a drug
d) A ratio used to evaluate the elimination of a drug

22. Idiosyncratic reaction of a drug is:
a) A type of hypersensitivity reaction
b) A type of drug antagonism
c) Unpredictable, inherent, qualitatively abnormal reaction to a drug
d) Quantitatively exaggerated response

No comments:

Post a Comment